Label Changes for:
Sumavel DosePro (sumatriptan) injection for subcutaneous use
Changes have been made to the CONTRAINDICATIONS sections of the safety label.
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – June 2011
Do not use within 24 hours of treatment with Ergotamine-Containing or Ergot-Type Medications or Other 5-HT1 Agonists (e.g. triptans)
- ...(with the exception of a single dose of another sumatriptan product, provided the doses are separated by at least 1 hour)